Finance

Beta
Ask
Lists
AGFB:EBR
Agfa Gevaert NV
€0.42
-0.59%
(-0.0025) 1D
Jun 12, 12:41:48 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for AGFB...
Open
€0.42
High
€0.42
Low
€0.41
Mkt. cap
64.34M
Avg. vol.
88.33K
Volume
45.49K
52-wk high
€1.18
52-wk low
€0.41
EPS
-€0.40
Shares outstanding
154.82M
No. of employees
4K
Open
€0.42
High
€0.42
Low
€0.41
Mkt. cap
64.34M
Avg. vol.
88.33K
Volume
45.49K
52-wk high
€1.18
52-wk low
€0.41
EPS
-€0.40
Shares outstanding
154.82M
No. of employees
4K
Analyst outlook
Analyst Ratings
Based on 1 analyst giving stock ratings to AGFB in the past 3 months
Sell
Buy
0
Hold
0
Sell
1
12 month forecast
Based on 1 Wall Street analyst offering 12 month price targets for AGFB in the last 3 months.
Highest
Current €0.42
€0.40 (-4.76%)
Average
€0.40 (-4.76%)
Lowest
€0.40 (-4.76%)
News stories
From sources across the web
Profile
Agfa-Gevaert N.V. is a Belgian-German multinational corporation that develops, manufactures, and distributes analogue and digital imaging products, software, and systems. The company began in 1867, as a dye manufacturer under the name Aktien-Gesellschaft für Anilin-Fabrikation. In 1925, the company merged with several other German chemical companies to become chemicals giant IG Farben. AGFA was reconstituted from the remnants of IG Farben in 1952. Agfa photographic film and cameras were once prominent consumer products. In 2004, the consumer imaging division was sold to a company founded via management buyout. AgfaPhoto GmbH, as the new company was called, filed for bankruptcy after a year, and its brands are now licensed to other companies by AgfaPhoto Holding GmbH, a holding firm. Today Agfa-Gevaert's commerce is 100% business-to-business. Wikipedia
About Agfa Gevaert NV
CEOPascal Juéry
Employees4.21K
Founded1867
HeadquartersMortsel, Antwerp, Belgium
SectorHealth care
Websiteagfa.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
281.00M
257.00M
306.00M
236.00M
Cost of goods sold
196.00M
188.00M
-
160.00M
Cost of revenue
196.00M
188.00M
-
160.00M
Research and development expenses
17.00M
16.00M
-
17.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
69.00M
64.00M
-
62.00M
Operating expense
52.00M
79.00M
-
80.00M
Total operating expenses
248.00M
267.00M
-
240.00M
Operating income
33.00M
-10.00M
-
-4.00M
Other non operating income
-
-5.00M
-
-4.00M
EBT including unusual items
32.00M
-16.00M
-
-10.00M
EBT excluding unusual items
32.00M
-16.00M
-
-10.00M
Income tax expense
1.00M
2.00M
-
-3.00M
Effective tax rate
3.12%
-12.50%
-
30.00%
Other operating expenses
-33.00M
-1.00M
-
1.00M
Net income
30.00M
-19.00M
-
-12.00M
Net profit margin
10.68%
-7.39%
-
-5.08%
Earnings per share
0.02
-
0.15
-0.02
Interest and investment income
2.00M
2.00M
-
-
Interest expense
-3.00M
-3.00M
-
-2.00M
Net interest expenses
-1.00M
-1.00M
-
-2.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
38.00M
-5.00M
-
1.00M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer